OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
SGS Invests in New E&L Laboratory in India
SGS is investing in a new E&L lab in Navi Mumbai, India, that will provide testing services.
SGS announced on Oct. 12, 2021, that it is investing in a new extractables and leachables (E&L) testing laboratory in Navi Mumbai, India. The lab is set to open by the end of 2021 and will provide testing services for verifying product safety for pharmaceutical, biopharmaceutical, and medical device companies in Southeast Asia.
The new lab will be approximately 3000 ft.2 and will offer a broad spectrum of the latest E&L testing solutions, including:
- gas chromatography–mass spectrometry (GC–MS) and headspace–GC/MS for the analysis of semi-volatile and volatile components
- liquid chromatography with tandem mass spectrometry (LC–MSMS) for the quantitative analysis of trace leachable components
- high resolution LC–MSMS to generate data that supports identification of unknown components
- and inductively coupled plasma–MS to quantitate screening and identification of inorganics.
This laboratory in India will complement SGS's existing testing network. The company has three other E&L centers of excellence located in the United States, Germany, and China.
Source: SGS